← All Investors
BIOMARIN PHARMACEUTICAL INC
BMRN 1.25 05-15-27
Holders
2
Combined Value
$61M
Combined Shares
63,485,000
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|---|---|---|---|---|---|
| Howard Marks - Oaktree Capital | $54M | 0.86% | ~$0.96 | — | Bought Q1 2026 | Q1 2026 |
| Israel Englander - Millennium Management | $7.2M | 0.00% | ~$0.95 | — | Sold Q1 2026 | Q1 2026 |
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q1 2026 | Howard Marks - Oaktree Capital | BUY | +$13M | ~$0.96 |
| Q1 2026 | Israel Englander - Millennium Management | SELL | −$9.6M | ~$0.96 |
| Q4 2025 | Howard Marks - Oaktree Capital | BUY | +$21M | ~$0.96 |
| Q4 2025 | Israel Englander - Millennium Management | SELL | −$7.2M | ~$0.96 |
| Q3 2025 | Israel Englander - Millennium Management | NEW BUY | +$23M | ~$0.95 |
| Q3 2025 | Howard Marks - Oaktree Capital | BUY | +$17M | ~$0.95 |
| Q2 2025 | Howard Marks - Oaktree Capital | NEW BUY | +$1.4M | ~$0.95 |
| Q1 2025 | Ken Fisher - Fisher Investments | SOLD OUT | −$17K | ~$0.93 |
| Q4 2024 | Ken Fisher - Fisher Investments | NEW BUY | +$17K | ~$0.93 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q1 2026 | 2 | 63,485,000 | +6.5% | $61M | $0.96 |
| Q4 2025 | 2 | 59,618,000 | +33.3% | $57M | $0.96 |
| Q3 2025 | 2 | 44,719,000 | +2919.5% | $42M | $0.95 |
| Q2 2025 | 1 | 1,481,000 | +7694.7% | $1.4M | $0.95 |
| Q4 2024 | 1 | 19,000 | — | $17K | $0.93 |